Diamond Bar medical company's product gets go-ahead from FDA

| | Comments (0) |
Diamond Bar-based Biosense Webster Inc., which works to diagnosis and treatment of cardiac arrhythmias, recently announced that the U.S. Food and Drug Administration has cleared the company's CARTO-3 System, a three-dimensional imaging technology, for marketing.  Information: www.biosensewebster.com

Leave a comment


Type the characters you see in the picture above.

About this blog

Covering the local business scene for Inland Empire with the latest news.

About this Entry

This page contains a single entry by Matt Wrye published on October 20, 2009 11:30 AM.

Ontario design agency garners award for work in Claremont was the previous entry in this blog.

Consumer counseling nonprofit to hold ID theft prevention seminar is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Recent Comments

Powered by Movable Type 4.25

Breaking News

Advertisement